Chief Medical Officer and Head Global Medical & Scientific Affairs at Roche Diagnostics / Centralised and Point of Care Solutions
Ralph has been Chief Medical Officer and Head Global Medical & Scientific Affairs for Centralised and Point of Care Solutions (CPS) within the Roche Diagnostics division since May 2014.
Ralph began his career at Roche in 2000 as a Medical Director and Clinical Scientist within Roche Pharma Development in Basel, Switzerland. Before joining Roche Diagnostics, Ralph served as Global Head Drug Safety Science – Cardiometabolism within the Roche Pharma Development organization.
Since 2012 Ralph has also been the Roche coordinator of the Innovative Medicines Initiative’s (IMI) project Eu2P, a public-private partnership with a consortium of 7 European universities, 15 pharmaceutical companies and the European and French Medicines Agencies.
Ralph received a Medical Degree (M.D.) and Doctor of Medicine (Dr. Med.) from the University of Munich Medical School, Germany, and a Master of Business and Administration (M.B.A.) from the William E. Simon Graduate School of Business Administration at the University of Rochester, New York, USA. He is a board certified physician and surgeon and lecturer at the University of Zurich Medical School.
1 blog from the author
Posted on 22.05.2018
How can we manage preeclampsia risk during pregnancy?
Preeclampsia is a serious pregnancy disorder occurring only during pregnancy. To mark World Preeclampsia Day (May 22), I would like to share some insights on how to make pregnancy after preeclampsia as safe as possible for women and babies. One of the questions we hear most frequently from women who have experienced preeclampsia is: ‘Is […]